Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6

Benzinga Newsdesk www.benzinga.com Positive 66.2%

Neg 0% Neu 0% Pos 66.2%

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $5.15 to $6.